Replies to post #233202 on Biotech Values

[DewDiligence]

NBRV—(-38%)—ceases operations:

https://finance.yahoo.com/news/nabriva-therapeutics-provides-corporate-120100923.html

To preserve cash in order to adequately fund an orderly wind down and enable a sale of its assets, Nabriva plans to terminate all employees, including officers of the Company, not deemed necessary to execute an orderly wind-down of the Company.

…Nabriva’s Board of Directors continues to evaluate alternatives to maximize shareholder value. In the event that the Board of Directors determines that a liquidation and dissolution of the Company pursuant to a Plan of Dissolution to be approved by shareholders is the best method to maximize shareholder value, the Company would file proxy materials with the Securities and Exchange Commission and schedule an extraordinary meeting of its shareholders to seek approval of such a Plan of Dissolution as required.

I expect to see NBRV listed in the table in #msg-170737365 in due course.